These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

476 related articles for article (PubMed ID: 33948452)

  • 1. Direct acting anti-hepatitis C combinations as potential COVID-19 protease inhibitors.
    Hamed M; El-Hasab M; Mansour FR
    Virusdisease; 2021 Jun; 32(2):279-285. PubMed ID: 33948452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repurposing of known anti-virals as potential inhibitors for SARS-CoV-2 main protease using molecular docking analysis.
    Hakmi M; Bouricha EM; Kandoussi I; Harti JE; Ibrahimi A
    Bioinformation; 2020; 16(4):301-306. PubMed ID: 32773989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of Potent SARS-CoV-2 Inhibitors from Approved Antiviral Drugs via Docking and Virtual Screening.
    Chtita S; Belhassan A; Aouidate A; Belaidi S; Bouachrine M; Lakhlifi T
    Comb Chem High Throughput Screen; 2021; 24(3):441-454. PubMed ID: 32748740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current Strategies of Antiviral Drug Discovery for COVID-19.
    Mei M; Tan X
    Front Mol Biosci; 2021; 8():671263. PubMed ID: 34055887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-HCV and anti-malaria agent, potential candidates to repurpose for coronavirus infection: Virtual screening, molecular docking, and molecular dynamics simulation study.
    Hosseini FS; Amanlou M
    Life Sci; 2020 Oct; 258():118205. PubMed ID: 32777300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rational Drug Discovery of HCV Helicase Inhibitor: Improved Docking Accuracy with Multiple Seeding in AutoDock Vina and In Situ Minimization.
    Lim SK; Othman R; Yusof R; Heh CH
    Curr Comput Aided Drug Des; 2017; 13(2):160-169. PubMed ID: 27903217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-based virtual screening of phytochemicals and repurposing of FDA approved antiviral drugs unravels lead molecules as potential inhibitors of coronavirus 3C-like protease enzyme.
    Bahadur Gurung A; Ajmal Ali M; Lee J; Abul Farah M; Mashay Al-Anazi K
    J King Saud Univ Sci; 2020 Sep; 32(6):2845-2853. PubMed ID: 32837113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In silico prediction of potential inhibitors for the main protease of SARS-CoV-2 using molecular docking and dynamics simulation based drug-repurposing.
    Kumar Y; Singh H; Patel CN
    J Infect Public Health; 2020 Sep; 13(9):1210-1223. PubMed ID: 32561274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fast Identification of Possible Drug Treatment of Coronavirus Disease-19 (COVID-19) through Computational Drug Repurposing Study.
    Wang J
    J Chem Inf Model; 2020 Jun; 60(6):3277-3286. PubMed ID: 32315171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of Potential Inhibitors of 3CL Protease of SARS-CoV-2 From ZINC Database by Molecular Docking-Based Virtual Screening.
    Abdusalam AAA; Murugaiyah V
    Front Mol Biosci; 2020; 7():603037. PubMed ID: 33392261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MCCS: a novel recognition pattern-based method for fast track discovery of anti-SARS-CoV-2 drugs.
    Feng Z; Chen M; Xue Y; Liang T; Chen H; Zhou Y; Nolin TD; Smith RB; Xie XQ
    Brief Bioinform; 2021 Mar; 22(2):946-962. PubMed ID: 33078827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repurposing of Drugs for SARS-CoV-2 Using Inverse Docking Fingerprints.
    Jukič M; Kores K; Janežič D; Bren U
    Front Chem; 2021; 9():757826. PubMed ID: 35028304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Computational screening of FDA approved drugs of fungal origin that may interfere with SARS-CoV-2 spike protein activation, viral RNA replication, and post-translational modification: a multiple target approach.
    Singh R; Gautam A; Chandel S; Sharma V; Ghosh A; Dey D; Roy S; Ravichandiran V; Ghosh D
    In Silico Pharmacol; 2021; 9(1):27. PubMed ID: 33842191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Docking-based virtual screening of known drugs against murE of Mycobacterium tuberculosis towards repurposing for TB.
    Brindha S; Sundaramurthi JC; Velmurugan D; Vincent S; Gnanadoss JJ
    Bioinformation; 2016; 12(8):359-367. PubMed ID: 28275291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug repurposing using computational methods to identify therapeutic options for COVID-19.
    Mahdian S; Ebrahim-Habibi A; Zarrabi M
    J Diabetes Metab Disord; 2020 Dec; 19(2):691-699. PubMed ID: 32837954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential Inhibitors for Novel Coronavirus Protease Identified by Virtual Screening of 606 Million Compounds.
    Fischer A; Sellner M; Neranjan S; Smieško M; Lill MA
    Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32455534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential therapeutic and pharmacological strategies for SARS-CoV2.
    Ghareeb DA; Saleh SR; Nofal MS; Kaddah MMY; Hassan SF; Seif IK; El-Zahaby SA; Khedr SM; Kenawy MY; Masoud AA; Soudi SA; Sobhy AA; Sery JG; El-Wahab MGA; Elmoneam AAA; Al-Mahallawi AM; El-Demellawy MA
    J Pharm Investig; 2021; 51(3):281-296. PubMed ID: 33688448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploiting cheminformatic and machine learning to navigate the available chemical space of potential small molecule inhibitors of SARS-CoV-2.
    Kumar A; Loharch S; Kumar S; Ringe RP; Parkesh R
    Comput Struct Biotechnol J; 2021; 19():424-438. PubMed ID: 33391634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug Repurposing Strategy (DRS): Emerging Approach to Identify Potential Therapeutics for Treatment of Novel Coronavirus Infection.
    Sahoo BM; Ravi Kumar BVV; Sruti J; Mahapatra MK; Banik BK; Borah P
    Front Mol Biosci; 2021; 8():628144. PubMed ID: 33718434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repurposing Antiviral Protease Inhibitors Using Extracellular Vesicles for Potential Therapy of COVID-19.
    Kumar S; Zhi K; Mukherji A; Gerth K
    Viruses; 2020 Apr; 12(5):. PubMed ID: 32357553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.